Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 21% ± 7% | |
endothelial cell of lymphatic vessel | 5 studies | 31% ± 6% | |
ciliated cell | 3 studies | 28% ± 8% | |
macrophage | 3 studies | 23% ± 3% | |
monocyte | 3 studies | 20% ± 3% | |
oligodendrocyte | 3 studies | 22% ± 2% |
Insufficient scRNA-seq data for expression of MBOAT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1066.26 | 180 / 180 | 100% | 37.75 | 428 / 430 |
intestine | 100% | 1345.99 | 966 / 966 | 98% | 22.04 | 514 / 527 |
breast | 100% | 1237.32 | 457 / 459 | 98% | 48.00 | 1092 / 1118 |
lung | 100% | 682.44 | 577 / 578 | 97% | 23.75 | 1123 / 1155 |
stomach | 100% | 1004.17 | 358 / 359 | 93% | 19.07 | 266 / 286 |
thymus | 100% | 730.14 | 651 / 653 | 93% | 14.54 | 561 / 605 |
esophagus | 100% | 638.26 | 1443 / 1445 | 92% | 16.03 | 169 / 183 |
uterus | 100% | 1389.75 | 170 / 170 | 92% | 21.76 | 423 / 459 |
skin | 94% | 424.06 | 1705 / 1809 | 96% | 28.58 | 455 / 472 |
bladder | 100% | 764.10 | 21 / 21 | 88% | 22.54 | 445 / 504 |
prostate | 100% | 870.60 | 245 / 245 | 83% | 10.33 | 416 / 502 |
pancreas | 91% | 290.31 | 297 / 328 | 92% | 21.42 | 164 / 178 |
kidney | 98% | 473.96 | 87 / 89 | 60% | 5.40 | 540 / 901 |
liver | 67% | 153.87 | 151 / 226 | 60% | 11.85 | 243 / 406 |
spleen | 100% | 647.65 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.99 | 1 / 1 |
adipose | 99% | 590.47 | 1197 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 88% | 266.07 | 227 / 258 | 11% | 1.28 | 25 / 230 |
tonsil | 0% | 0 | 0 / 0 | 98% | 19.43 | 44 / 45 |
blood vessel | 96% | 363.37 | 1286 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 669.53 | 862 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 21.44 | 74 / 80 |
heart | 89% | 299.52 | 763 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 52% | 6.94 | 15 / 29 |
brain | 14% | 65.83 | 364 / 2642 | 10% | 0.99 | 74 / 705 |
muscle | 18% | 32.42 | 143 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010975 | Biological process | regulation of neuron projection development |
GO_0008654 | Biological process | phospholipid biosynthetic process |
GO_0036150 | Biological process | phosphatidylserine acyl-chain remodeling |
GO_0030258 | Biological process | lipid modification |
GO_0036152 | Biological process | phosphatidylethanolamine acyl-chain remodeling |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0047144 | Molecular function | 2-acylglycerol-3-phosphate O-acyltransferase activity |
GO_0003841 | Molecular function | 1-acylglycerol-3-phosphate O-acyltransferase activity |
GO_0016746 | Molecular function | acyltransferase activity |
GO_0106263 | Molecular function | 1-acylglycerophosphoserine O-acyltransferase activity |
GO_0047184 | Molecular function | 1-acylglycerophosphocholine O-acyltransferase activity |
GO_0106262 | Molecular function | 1-acylglycerophosphoethanolamine O-acyltransferase activity |
Gene name | MBOAT1 |
Protein name | Lysophospholipid acyltransferase 1 (LPLAT 1) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (1-acylglycerophosphoserine O-acyltransferase MBOAT1) (EC 2.3.1.n6) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 1) (O-acyltransferase domain-containing protein 1) |
Synonyms | OACT1 |
Description | FUNCTION: Acyltransferase which catalyzes the transfer of an acyl group from an acyl-CoA towards a lysophospholipid producing a phospholipid and participates in the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle . Acts on lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero-3-phospho-L-serine or LPS) and lysophosphatidylethanolamine (1-acyl-sn-glycero-3-phosphoethanolamine or LPE), and to a lesser extend lysophosphatidylcholine . Prefers oleoyl-CoA as the acyl donor and 1-oleoyl-LPE as acceptor . May play a role in neurite outgrowth during neuronal differentiation (By similarity). . |
Accessions | ENST00000324607.8 [Q6ZNC8-1] Q6ZNC8 |